Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELOXX PHARMACEUTICALS, INC.

(ELOX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 42229416038,038,0-
Enterprise Value (EV)1 42229416038,038,038,0
P/E ratio -8,28x-5,49x-4,63x-0,47x-0,85x-0,74x
Yield ------
Capitalization / Revenue -----65,8x
EV / Revenue -----65,8x
EV / EBITDA ------
Price to Book ------
Nbr of stocks (in thousands) 35 11640 00340 15386 25286 252-
Reference price (USD) 12,07,363,980,440,440,44
Announcement Date 03/08/201903/06/202003/12/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -----0,58
EBITDA ------
Operating profit (EBIT)1 -47,6-50,6-33,5-65,1-48,1-59,4
Operating Margin ------10 310%
Pre-Tax Profit (EBT)1 -47,1-50,9-34,6-64,8-47,6-59,1
Net income1 -47,2-50,9-34,6-64,8-47,6-59,1
Net margin ------10 256%
EPS2 -1,45-1,34-0,86-0,94-0,52-0,60
Dividend per Share ------
Announcement Date 03/08/201903/06/202003/12/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -8,41-35,7-10,2-10,7-10,5-11,5
Operating Margin ------
Pre-Tax Profit (EBT)1 -8,69-36,1-9,89-10,4-10,5-11,6
Net income1 -8,69-36,1-9,89-10,4-10,5-11,6
Net margin ------
EPS2 -0,22-0,54-0,11-0,12-0,13-0,13
Dividend per Share ------
Announcement Date 05/07/202108/16/202111/08/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 --39,4-28,2-53,8-48,8-59,9
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 0,240,04-0,08--
Capex / Sales ------
Announcement Date 03/08/201903/06/202003/12/2021---
1 USD in Million
Key data
Capitalization (USD) 37 951 040
Number of employees 25
Avg. Exchange 20 sessions (USD) 195 879
Average Daily Capital Traded 0,52%
EPS & Dividend